JP7398716B2 - ペプチド、組成物、及び、気分障害を治療、予防、又は改善する方法 - Google Patents

ペプチド、組成物、及び、気分障害を治療、予防、又は改善する方法 Download PDF

Info

Publication number
JP7398716B2
JP7398716B2 JP2021555111A JP2021555111A JP7398716B2 JP 7398716 B2 JP7398716 B2 JP 7398716B2 JP 2021555111 A JP2021555111 A JP 2021555111A JP 2021555111 A JP2021555111 A JP 2021555111A JP 7398716 B2 JP7398716 B2 JP 7398716B2
Authority
JP
Japan
Prior art keywords
peptide
present
amino acid
seq
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021555111A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021090894A1 (https=
Inventor
耕作 大日向
宸東 徐
秀幸 鈴木
大 佐藤
彰 伊藤
裕樹 樋口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kameda Seika Co Ltd
Kazusa DNA Research Institute Foundation
Kyoto University NUC
Original Assignee
Kameda Seika Co Ltd
Kazusa DNA Research Institute Foundation
Kyoto University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kameda Seika Co Ltd, Kazusa DNA Research Institute Foundation, Kyoto University NUC filed Critical Kameda Seika Co Ltd
Publication of JPWO2021090894A1 publication Critical patent/JPWO2021090894A1/ja
Application granted granted Critical
Publication of JP7398716B2 publication Critical patent/JP7398716B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2021555111A 2019-11-05 2020-11-05 ペプチド、組成物、及び、気分障害を治療、予防、又は改善する方法 Active JP7398716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019200911 2019-11-05
JP2019200911 2019-11-05
PCT/JP2020/041417 WO2021090894A1 (ja) 2019-11-05 2020-11-05 ペプチド、組成物、及び、気分障害を治療、予防、又は改善する方法

Publications (2)

Publication Number Publication Date
JPWO2021090894A1 JPWO2021090894A1 (https=) 2021-05-14
JP7398716B2 true JP7398716B2 (ja) 2023-12-15

Family

ID=75848461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021555111A Active JP7398716B2 (ja) 2019-11-05 2020-11-05 ペプチド、組成物、及び、気分障害を治療、予防、又は改善する方法

Country Status (5)

Country Link
US (1) US20220370546A1 (https=)
JP (1) JP7398716B2 (https=)
CN (1) CN114641484B (https=)
TW (1) TW202132325A (https=)
WO (1) WO2021090894A1 (https=)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004107352A (ja) 1992-11-13 2004-04-08 Univ Thomas Jefferson Ｔ細胞増殖を阻害する化合物及び同化合物の使用方法
JP2005507363A (ja) 2001-02-16 2005-03-17 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 血管新生阻害トリペプチド、組成物およびそれらの使用方法
JP2006502079A (ja) 2001-11-19 2006-01-19 ベクトン・ディキンソン・アンド・カンパニー 細胞接着、増殖および分泌を促進するペプチド
JP2008528002A (ja) 2005-01-25 2008-07-31 セル セラピューティクス インコーポレーテッド 改善された生体内半減期を有する生物学的に活性なタンパク質
JP2010532761A (ja) 2007-07-03 2010-10-14 ノノ インコーポレイテッド 不安に対する治療法
WO2011126054A1 (ja) 2010-04-07 2011-10-13 国立大学法人京都大学 生理活性ペプチド
JP2014162735A (ja) 2013-02-22 2014-09-08 Kyoto Univ 抗うつ剤又は抗不安剤
JP2016222646A (ja) 2015-05-27 2016-12-28 キリン株式会社 ペプチドを含む炎症抑制のための組成物
JP2017048124A (ja) 2015-08-31 2017-03-09 森永乳業株式会社 アミノペプチダーゼａ阻害剤
WO2017042282A1 (en) 2015-09-08 2017-03-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Soybean allergy related epitopes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004394B1 (en) * 1978-03-02 1981-04-15 Akzo N.V. Psychopharmacological peptides, process for their preparation and their pharmaceutical formulations
JPH08217794A (ja) * 1995-02-15 1996-08-27 Bio Kosumosu:Kk 環状ペンタペプチド
CA2744365A1 (en) * 2008-11-20 2010-05-27 Panacea Biotec Ltd. Tumor necrosis factor alpha inhibiting peptides and uses thereof
WO2016190395A1 (ja) * 2015-05-27 2016-12-01 キリン株式会社 ペプチドを含む炎症抑制のための組成物

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004107352A (ja) 1992-11-13 2004-04-08 Univ Thomas Jefferson Ｔ細胞増殖を阻害する化合物及び同化合物の使用方法
JP2005507363A (ja) 2001-02-16 2005-03-17 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 血管新生阻害トリペプチド、組成物およびそれらの使用方法
JP2006502079A (ja) 2001-11-19 2006-01-19 ベクトン・ディキンソン・アンド・カンパニー 細胞接着、増殖および分泌を促進するペプチド
JP2008528002A (ja) 2005-01-25 2008-07-31 セル セラピューティクス インコーポレーテッド 改善された生体内半減期を有する生物学的に活性なタンパク質
JP2010532761A (ja) 2007-07-03 2010-10-14 ノノ インコーポレイテッド 不安に対する治療法
WO2011126054A1 (ja) 2010-04-07 2011-10-13 国立大学法人京都大学 生理活性ペプチド
JP2014162735A (ja) 2013-02-22 2014-09-08 Kyoto Univ 抗うつ剤又は抗不安剤
JP2016222646A (ja) 2015-05-27 2016-12-28 キリン株式会社 ペプチドを含む炎症抑制のための組成物
JP2017048124A (ja) 2015-08-31 2017-03-09 森永乳業株式会社 アミノペプチダーゼａ阻害剤
WO2017042282A1 (en) 2015-09-08 2017-03-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Soybean allergy related epitopes

Also Published As

Publication number Publication date
CN114641484B (zh) 2024-08-09
CN114641484A (zh) 2022-06-17
US20220370546A1 (en) 2022-11-24
TW202132325A (zh) 2021-09-01
WO2021090894A1 (ja) 2021-05-14
JPWO2021090894A1 (https=) 2021-05-14

Similar Documents

Publication Publication Date Title
JP6189994B2 (ja) ジペプチジルペプチダーゼ−ｉｖ阻害用飲食品組成物
JP6344796B2 (ja) 高齢者用アルツハイマー型認知症改善剤
JP5832049B2 (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP2015084694A (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
WO2013133032A1 (ja) ジペプチジルペプチダーゼ－ｉｖ阻害剤
WO2022202985A1 (ja) ペプチド、及び該ペプチドを有効成分として含有する組成物
JP2007261999A (ja) ローヤルゼリー由来の降圧ペプチド
JPWO2005061529A1 (ja) アンジオテンシン変換酵素阻害ペプチド
JP2024074955A (ja) ペプチド、組成物及び気分障害を治療、予防、又は改善する方法
JP7398716B2 (ja) ペプチド、組成物、及び、気分障害を治療、予防、又は改善する方法
JP2013184962A (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP2024168267A (ja) 筋萎縮抑制用組成物
JP6589011B2 (ja) 脳機能障害改善用経口組成物
JP4395658B2 (ja) コレステロール再上昇抑制用組成物およびその用法
TW202108601A (zh) 胜肽、組成物、以及飢餓肽分泌促進劑
HK40035080A (en) Peptide, composition, and method for treating, preventing, or ameliorating mood disorder
WO2026033633A1 (ja) ペプチド及び組成物
JP2005255670A (ja) ローヤルゼリー由来の降圧ペプチド
JP2025082072A (ja) ビフィドバクテリウム・ビフィダム増殖促進用組成物
JP2024033770A (ja) 脳機能低下の予防、治療、又は軽減用組成物、及び、アミロイドβ凝集体の蓄積抑制のための組成物
HK40035080B (zh) 肽、组合物及治疗、预防或改善心境障碍的方法
JP2021024847A (ja) 脳機能障害改善用組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220331

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230418

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20230418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230418

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230914

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231031

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231124

R150 Certificate of patent or registration of utility model

Ref document number: 7398716

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150